Overview

Bioequivalence Study of Generic Celecoxib 200 mg Capsules

Status:
NOT_YET_RECRUITING
Trial end date:
2024-10-04
Target enrollment:
Participant gender:
Summary
To determine and compare the rate and extent of absorption of a test formulation with that of a reference innovator formulation when given as equal labeled dose in healthy subjects under fasting conditions
Phase:
PHASE1
Details
Lead Sponsor:
International Bio service
Treatments:
Celecoxib